Gilead Faces Fights Over Hepatitis C and H.I.V. Drugs

Thursday, January 28, 2016 - 22:14 in Health & Medicine

The company may face legal action in Massachusetts unless it drops prices for its hepatitis C drugs. In California, it is being sued over patents for an H.I.V. treatment.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net